Exploratory Clinical Study on the Safety of STR-P004

Summary

This is an open-label, multiple-dose escalation IIT clinical study aimed at evaluating the safety, tolerability, PK, and preliminary efficacy of STR-P004 in adult patients with relapsed or refractory autoimmune diseases.

Timeline

Start

2025-09-16

Primary completion

2026-08-15

Completion

2026-09-14

Drugs

Indications